Mayo Clinic doctor breaks down weight-loss drug’s potential for sleep apnea

Cardiologist Dr. Virend Somers discusses how the weight-loss drug retatrutide significantly reduced obstructive sleep apnea severity and improved cardiovascular risk factors in patients with and without type 2 diabetes.